Prot# A3921024: A Long-Term, Open-Label Follow -Up Study of CP-690,550, A Moderately Selective Janus-Kinase-3 Inhibitor, For Treatment of Rheumatoid Arthritis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/084/10/11

Funding

  • ICON Clinical Research, LLC (A3921024)
  • Pfizer Inc. (A3921024)